Taribavirin offers a safe, effective alternative for chronic hepatitis C
Wednesday, September 22, 2010 - 09:07
in Health & Medicine
Researchers at Cedars-Sinai Medical Center and 50 other centers found that weight-based dosing of taribavirin reduces rates of anemia while increasing sustained virologic response (SVR) in patients with chronic hepatitis C (HCV). Full details of this study are available in the October issue of Hepatology.